Skip to main content
Top
Published in: Diabetologia 12/2009

01-12-2009 | Commentary

Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors

Authors: C. Messier, M. Gagnon

Published in: Diabetologia | Issue 12/2009

Login to get access

Excerpt

The possible association between type 2 diabetes and dementia, Alzheimer’s disease in particular, has been shrouded in confusion for some time, with some researchers noting that Alzheimer’s patients are rarely diabetic [1] but others suggesting diabetes to be a major risk factor for the disease [2]. Since an earlier review of the evidence [3], a number of things have become clearer. First, histopathological examinations of the brains of type 1 and type 2 diabetic patients have demonstrated that diabetes as such does not produce the amyloid plaques and neurofibrillary tangles considered hallmarks of Alzheimer’s disease [4]—a finding supported by a recent extensive post-mortem examination [5]. Second, research has shown that, in non-demented patients with type 2 diabetes, cognitive deficits are relatively mild before the age of 70 years, although they increase in frequency and severity thereafter [6]. Finally, people with type 2 diabetes who maintain less than optimal glycaemic control (i.e. with many occurrences of high blood glucose levels) are more likely to start manifesting cognitive deficits. Interestingly, improving glycaemic control in this population can reduce these cognitive deficits [7], suggesting that cognitive deficits might not be permanent in patients in whom presentation is early. …
Literature
1.
go back to reference Nielson KA, Nolan JH, Berchtold NC, Sandman CA, Mulnard RA, Cotman CW (1996) Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease? [see comments]. J Am Geriatr Soc 44:897–904PubMed Nielson KA, Nolan JH, Berchtold NC, Sandman CA, Mulnard RA, Cotman CW (1996) Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease? [see comments]. J Am Geriatr Soc 44:897–904PubMed
2.
go back to reference Messier C (2003) Diabetes, Alzheimer’s disease and apolipoprotein genotype. Exp Gerontol 38:941–946CrossRefPubMed Messier C (2003) Diabetes, Alzheimer’s disease and apolipoprotein genotype. Exp Gerontol 38:941–946CrossRefPubMed
3.
go back to reference Messier C, Gagnon M (1996) Glucose regulation and cognitive functions: relation to Alzheimer’s disease and diabetes. Behav Brain Res 75:1–11CrossRefPubMed Messier C, Gagnon M (1996) Glucose regulation and cognitive functions: relation to Alzheimer’s disease and diabetes. Behav Brain Res 75:1–11CrossRefPubMed
4.
go back to reference Heitner J, Dickson D (1997) Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology 49:1306–1311PubMed Heitner J, Dickson D (1997) Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology 49:1306–1311PubMed
5.
go back to reference Alafuzoff I, Aho L, Helisalmi S, Mannermaa A, Soininen H (2009) beta-Amyloid deposition in brains of subjects with diabetes. Neuropathol Appl Neurobiol 35:60–68CrossRefPubMed Alafuzoff I, Aho L, Helisalmi S, Mannermaa A, Soininen H (2009) beta-Amyloid deposition in brains of subjects with diabetes. Neuropathol Appl Neurobiol 35:60–68CrossRefPubMed
6.
go back to reference Ryan CM, Geckle M (2000) Why is learning and memory dysfunction in type 2 diabetes limited to older adults? Diabetes Metab Res Rev 16:308–315CrossRefPubMed Ryan CM, Geckle M (2000) Why is learning and memory dysfunction in type 2 diabetes limited to older adults? Diabetes Metab Res Rev 16:308–315CrossRefPubMed
7.
go back to reference Ryan CM, Freed MI, Rood JA, Cobitz AR, Waterhouse BR, Strachan MW (2006) Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 29:345–351CrossRefPubMed Ryan CM, Freed MI, Rood JA, Cobitz AR, Waterhouse BR, Strachan MW (2006) Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 29:345–351CrossRefPubMed
8.
go back to reference van den Berg E, Kloppenborg RP, Kessels RP, Kappelle LJ, Biessels GJ (2009) Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochim Biophys Acta 1792:470–481PubMed van den Berg E, Kloppenborg RP, Kessels RP, Kappelle LJ, Biessels GJ (2009) Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochim Biophys Acta 1792:470–481PubMed
9.
go back to reference Tiehuis AM, Mali WP, van Raamt AF et al (2009) Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes. J Neurol Sci 283:170–174CrossRefPubMed Tiehuis AM, Mali WP, van Raamt AF et al (2009) Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes. J Neurol Sci 283:170–174CrossRefPubMed
10.
go back to reference Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer’s disease. Neuron 63:287–303CrossRefPubMed Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer’s disease. Neuron 63:287–303CrossRefPubMed
11.
go back to reference Craft S, Teri L, Edland SD et al (1998) Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology 51:149–153PubMed Craft S, Teri L, Edland SD et al (1998) Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology 51:149–153PubMed
12.
go back to reference Dore G, Elias M, Robbins M, Elias P, Nagy Z (2009) Presence of the APOE ε4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine–Syracuse Study. Diabetologia. doi:10.1007/s00125-00009-01497-00122 PubMed Dore G, Elias M, Robbins M, Elias P, Nagy Z (2009) Presence of the APOE ε4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine–Syracuse Study. Diabetologia. doi:10.​1007/​s00125-00009-01497-00122 PubMed
13.
go back to reference Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E (2005) APOE genotype and cognitive decline in a middle-aged cohort. Neurology 64:268–276PubMed Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E (2005) APOE genotype and cognitive decline in a middle-aged cohort. Neurology 64:268–276PubMed
14.
go back to reference Knopman DS, Mosley TH, Catellier DJ, Coker LH (2009) Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimers Dement 5:207–214CrossRefPubMed Knopman DS, Mosley TH, Catellier DJ, Coker LH (2009) Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimers Dement 5:207–214CrossRefPubMed
15.
go back to reference Abi-Saab WM, Maggs DG, Jones T et al (2002) Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab 22:271–279CrossRefPubMed Abi-Saab WM, Maggs DG, Jones T et al (2002) Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab 22:271–279CrossRefPubMed
16.
go back to reference Craft S, Watson GS (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurology 3:169–178CrossRefPubMed Craft S, Watson GS (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurology 3:169–178CrossRefPubMed
17.
go back to reference Irie F, Fitzpatrick AL, Lopez OL et al (2008) Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. Arch Neurol 65:89–93CrossRefPubMed Irie F, Fitzpatrick AL, Lopez OL et al (2008) Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. Arch Neurol 65:89–93CrossRefPubMed
18.
go back to reference Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies—The Honolulu–Asia Aging Study. Diabetes 51:1256–1262CrossRefPubMed Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies—The Honolulu–Asia Aging Study. Diabetes 51:1256–1262CrossRefPubMed
19.
go back to reference Akomolafe A, Beiser A, Meigs JB et al (2006) Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol 63:1551–1555CrossRefPubMed Akomolafe A, Beiser A, Meigs JB et al (2006) Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol 63:1551–1555CrossRefPubMed
20.
go back to reference MacKnight C, Rockwood K, Awalt E, McDowell I (2002) Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 14:77–83CrossRefPubMed MacKnight C, Rockwood K, Awalt E, McDowell I (2002) Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 14:77–83CrossRefPubMed
21.
go back to reference Jellinger KA (2008) The pathology of "vascular dementia": a critical update. J Alzheimers Dis 14:107–123PubMed Jellinger KA (2008) The pathology of "vascular dementia": a critical update. J Alzheimers Dis 14:107–123PubMed
22.
go back to reference Thompson CS, Hakim AM (2009) Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis. Stroke 40:e322–e330CrossRefPubMed Thompson CS, Hakim AM (2009) Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis. Stroke 40:e322–e330CrossRefPubMed
Metadata
Title
Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors
Authors
C. Messier
M. Gagnon
Publication date
01-12-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1533-2

Other articles of this Issue 12/2009

Diabetologia 12/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.